Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer

American Journal of Surgery

Volumn 196, Issue 3, 2008, Pages 326-332

  Lombardi, Celestino Pio ^a   Bossola, Maurizio ^a   Princi, Pietro ^a   Boscherini, Mauro ^a   La Torre, Giuseppe ^a   Raffaelli, Marco ^a   Traini, Emanuela ^a   Salvatori, Massimo ^a   Pontecorvi, Alfredo ^a   Bellantone, Rocco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Circulating Tg mRNA; Recurrence; Thyroglobulin; Thyroid cancer

Indexed keywords

MESSENGER RNA; RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CLINICAL EXAMINATION; DISEASE FREE INTERVAL; DISTANT METASTASIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KAPLAN MEIER METHOD; LABORATORY TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY;

ADULT; FEMALE; HUMANS; IMMUNOASSAY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 49349098539     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.09.047     Document Type: Article

References (39)

1. Schlumberger M.J. Papillary and follicular thyroid carcinoma. N Engl J Med 338 (1998) 297-306
2. Mazzaferri E.L., and Kloos R.T. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86 (2001) 1447-1463
3. Mazzaferri E.L., and Kloos R.T. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?. J Clin Endocrinol Metab 87 (2002) 1490-1498
4. Ladenson P.W., Braverman L.E., Mazzaferri E.L., et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337 (1997) 888-896
5. Ladenson P.W. Strategies for thyrotropin use to monitor patients with treated thyroid carcinoma. Thyroid 9 (1999) 429-433
6. Mazzaferri E.L., Robbins J., Spencer C.A., et al. A consensus report of the role of the serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88 (2003) 1433-1441
7. Spencer C.A., Takeuchi M., and Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clin Chem 42 (1996) 164-173
8. Spencer C.A., and Wang C.C. Thyroglobulin measurement (techniques, clinical benefits, and pitfalls). Endocrinol Metab Clin North Am 24 (1995) 841-863
9. Rubello D., Casara D., Girelli M.E., et al. Clinical meaning of circulating anti-thyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 33 (1992) 1478-1480
10. Spencer C.A., Takeuchi M., Kazarosyan M., et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83 (1998) 1121-1127
11. Ditkoff B.A., Marvin M.R., Yemul S., et al. Detection of circulating thyroid cells in peripheral blood. Surgery 120 (1996) 959-965
12. Tallini G., Ghossein R.A., Emanuel J., et al. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 16 (1998) 1158-1166
13. Ringel M.D., Ladenson P.W., and Levine M.A. (1998) Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83 (1998) 4435-4442
14. Biscolla R.P., Cerutti J.M., and Maciel R.M. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 85 (2000) 3623-3627
15. Bugalho M.J., Domingues R.S., Pinto A.C., et al. Detection of thyroglobulin mRNA transcripts in peripheral blood of individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 145 (2001) 409-413
16. Bojunga J., Roddiger S., Stanisch M., et al. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer 82 (2000) 1650-1655
17. Denizot A., Delfino C., Dutour-Meyer A., et al. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer. Thyroid 13 (2003) 867-872
18. Bellantone R., Lombardi C.P., Bossola M., et al. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. Cancer 92 (2001) 2273-2279
19. Olsson C.A., de Vries G.M., Raffo A.J., et al. Preoperative reverse transcriptase polymerase chain reaction for prostatic specific antigen predicts treatment failure following radical prostatectomy. J Urol 155 (1996) 1557-1562
20. Ghossein R., Rosai J., Scher H.I., et al. Prognostic significance of detection of prostate specific antigen transcripts in the peripheral blood of patients with metastatic androgen independent prostatic carcinoma. Urology 50 (1997) 100-105
21. Ghossein R.A., Coit D., Brennan M., et al. Prognostic significance of peripheral blood and bone marrow tyrosinase mRNA in malignant melanoma. Clin Cancer Res 4 (1998) 419-428
22. Mellado B., Colomer D., Castel T., et al. Detection of circulating neoplastic cells by reverse transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 14 (1996) 2091-2097
23. Curry B.J., Myers K., and Hersey P. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 16 (1998) 1760-1769
24. Silva J.M., Dominguez G., Silva J., et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 7 (2001) 2821-2825
25. Stathopoulou A., Vlachonikolis I., Mavroudis D., et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20 (2002) 3404-3412
26. Guller U., Zajac P., Schnider A., et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236 (2002) 768-776
27. Minata M., Nishida N., Komeda T., et al. Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol 16 (2001) 445-451
28. Fraker D.L., Skarulis M., and Livolsi V. 1997 thyroid tumors. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer Principles and Practice of Oncology. 5th ed (1997), Lippincott-Raven, Philadelphia, PA 1269-1284
29. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Taskforce. Thyroid 16 (2006) 109-142
30. Sobin C.H., and Witteking C.H. TNM Classification of Malignant Tumor. 6th ed. (2002), Wiley, Hoboken, NJ 52-56
31. Pantel K., Cote R.J., and Fodstad O. Detection and clinical importance of micrometastatic disease. J Nat Cancer Inst 91 (1999) 1113-1124
32. Elisei R., Vivaldi A., Agate L., et al. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab 89 (2004) 33-39
33. Haber R.S. The diagnosis of recurrent thyroid cancer-a new approach. J Clin Endocrinol Metab 83 (1998) 4189-4190
34. Chelly J., Concordet J.P., and Kaplan J.C. Illegitimate transcription of any gene in any cell type. Proc Natl Acad Sci U S A 86 (1989) 2617-2621
35. Ringel M.A., Anderson J., Souza S.L., et al. Expression of the sodium iodide symporter and thyroglobulin gene are reduced in papillary thyroid cancer. Mod Pathol 14 (2001) 289-296
36. Ohta K., Endo T., and Onaya T. The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxydase in neoplastic human thyroid tissues. Biochem Biophys Res Comm 174 (1991) 1148-1153
37. Hoang-Vu C., Dralle H., Scheumann G., et al. Gene expression of differentiation and dedifferentiation markers in normal and malignant human thyroid tissues. Exp Clin Endocrinol 100 (1992) 51-56
38. Bertaux F., Noel M., Lasmoles F., et al. Identification of the exon structure and four alternative transcripts of the thyroglobulin-encoding gene. Gene 156 (1995) 297-301
39. Bertaux F., Noel M., Malthiery Y., et al. Demonstration of a heterogeneous transcription pattern of thyroglobulin mRNA in human thyroid tissue. Biochem Biophys Res Comm 178 (1991) 586-592